Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Y Locker

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|October 13, 1998
Hormonal therapy of breast cancerG Y Locker
Cancer|September 15, 1993
Elevated serum CA 125 secondary to tuberculous peritonitisS A Candocia, G Y Locker
Annals of Internal Medicine|June 1, 1993
More on medical malpracticeJ D Khandekar, G Y Locker
The New England Journal of Medicine|July 6, 1995
Hodgkin's disease and HIV infectionK B Knopf, G Y Locker
Cancer Treatment Reports|May 1, 1979
Experimental animal models of adriamycin cardiotoxicityJ H Doroshow, G Y Locker, C E Myers
The Journal of Clinical Investigation|January 1, 1980
Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicinJ H Doroshow, G Y Locker, C E Myers
Research Communications in Chemical Pathology and Pharmacology|November 1, 1979
The effect of doxorubicin on hepatic and cardiac glutathioneJ H Doroshow, G Y Locker, J Baldinger, et al.
The Journal of Clinical Investigation|October 1, 1981
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteineJ H Doroshow, G Y Locker, I Ifrim, et al.
Medicine|January 1, 1979
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literatureG Y Locker, J H Doroshow, L A Zwelling, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council TrialG Y Locker, T Hoeltgen, L Kilton, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|October 13, 1998
Hormonal therapy of breast cancerG Y Locker
Cancer|September 15, 1993
Elevated serum CA 125 secondary to tuberculous peritonitisS A Candocia, G Y Locker
Annals of Internal Medicine|June 1, 1993
More on medical malpracticeJ D Khandekar, G Y Locker
The New England Journal of Medicine|July 6, 1995
Hodgkin's disease and HIV infectionK B Knopf, G Y Locker
Cancer Treatment Reports|May 1, 1979
Experimental animal models of adriamycin cardiotoxicityJ H Doroshow, G Y Locker, C E Myers
The Journal of Clinical Investigation|January 1, 1980
Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicinJ H Doroshow, G Y Locker, C E Myers
Research Communications in Chemical Pathology and Pharmacology|November 1, 1979
The effect of doxorubicin on hepatic and cardiac glutathioneJ H Doroshow, G Y Locker, J Baldinger, et al.
The Journal of Clinical Investigation|October 1, 1981
Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteineJ H Doroshow, G Y Locker, I Ifrim, et al.
Medicine|January 1, 1979
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literatureG Y Locker, J H Doroshow, L A Zwelling, et al.
Cancer Treatment Reports|July 1, 1987
Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council TrialG Y Locker, T Hoeltgen, L Kilton, et al.
Pageof 3